Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

688.80INR
24 Mar 2017
Change (% chg)

Rs2.00 (+0.29%)
Prev Close
Rs686.80
Open
Rs687.95
Day's High
Rs697.00
Day's Low
Rs685.05
Volume
1,251,303
Avg. Vol
2,094,325
52-wk High
Rs895.00
52-wk Low
Rs621.90

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets
Monday, 20 Mar 2017 08:27am EDT 

Aurobindo Pharma Ltd : Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide . Says the product will be launched in Q1FY18. . guaifenesin and dextromethorphan hydrobromide extended-release tablets are AB rated generic equivalent of Reckitt Benckiser’S Mucinex DM tablets .Guaifenesin and dextromethorphan hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions.  Full Article

Aurobindo Pharma says co became aware of complaint from numerous states filed in Connecticut
Friday, 16 Dec 2016 02:46am EST 

Aurobindo Pharma Ltd : says co became aware of complaint from numerous states filed in Connecticut . says received subpoena in mar 2016 requesting non-product specific information . says have not received any further requests for information or subpoenas after March 2016 subpoena .says sales of Glyburide by our US subsidiary is not material.  Full Article

Aurobindo Pharma unit Arrow Generiques to buy select assets in France from Teva
Friday, 25 Nov 2016 07:21am EST 

Aurobindo Pharma Ltd : Aurobindo Pharma Ltd says Arrow Generiques to acquire select assets in France from Teva . Aurobindo Pharma Ltd says Arrow Generiques will integrate the products with existing commercial operations in France . Aurobindo Pharma Ltd says Arrow Generiques and Teva intend to ensure continuity of the supply of the products to the market. .Aurobindo Pharma - Arrow Generiques to buy right, title and interest in products calcium and calcium vitamin d3, including use of the orocal trademark..  Full Article

Aurobindo Pharma gets USFDA tentative approval for Dolutegravir
Thursday, 22 Sep 2016 03:12am EDT 

Aurobindo Pharma Ltd :Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market.  Full Article

Aurobindo Pharma receives USFDA approval for Linezolid injection
Monday, 8 Aug 2016 12:33am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Linezolid injection . Product is expected to be launched by Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for rosuvastatin calcium tablets
Wednesday, 20 Jul 2016 12:19am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for rosuvastatin calcium tablets .  Full Article

Aurobindo Pharma gets USFDA approval for hydromorphone hydrochloride tablets
Tuesday, 17 May 2016 01:50am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for hydromorphone hydrochloride tablets .  Full Article

Aurobindo Pharma gets US FDA approval for bupivacaine hydrochloride injection
Monday, 16 May 2016 12:20am EDT 

Aurobindo Pharma Ltd : Gets US FDA approval for bupivacaine hydrochloride injection .  Full Article

Aurobindo Pharma gets USFDA approval for Zolmitriptan tablets
Friday, 13 May 2016 05:03am EDT 

Aurobindo Pharma Ltd : Receives USFDA approval for Zolmitriptan tablets; product expected to be launched in Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for Fenofibrate tablets
Friday, 6 May 2016 01:28am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Fenofibrate tablets; product is expected to be launched in Q1 FY 2016-17 .  Full Article

More From Around the Web

BRIEF-Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets

* Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide